← Back to Search

Optical Biopsy System

ClariCore System for Prostate Cancer

N/A
Waitlist Available
Research Sponsored by Precision Biopsy, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days post-procedure
Awards & highlights

Study Summary

The purpose of the study is to collect information on prostrate biopsy tissue for use in developing a method determining the difference in normal and cancerous prostrate tissue using the ClariCore System.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ath the time of procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and ath the time of procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Effectiveness
Secondary outcome measures
Assessment of Pain
Incidence and frequency of adverse events
Other outcome measures
Clinical Success
Negative Predictive Value
Technical Success

Trial Design

1Treatment groups
Experimental Treatment
Group I: ClariCore SystemExperimental Treatment1 Intervention
ClairCore System study designed for data collection to build the prostrate tissue classification algorithm.

Find a Location

Who is running the clinical trial?

Precision Biopsy, Inc.Lead Sponsor
3 Previous Clinical Trials
485 Total Patients Enrolled
2 Trials studying Prostate Cancer
160 Patients Enrolled for Prostate Cancer
Sierra YearlyStudy DirectorSponsor GmbH

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Apr 2025